研究用フローサイトと理化学分析

世界のリサーチ分野のお客さまへ先端の検査装置のご案内です。

お問い合わせはこちら

sysmex

研究用フローサイトと理化学分析sysmex

CyFlow CD314 Azide Free

品番 BE160427
抗体名 Anti-Hu CD314 AZIDFREE,1D11
包装単位 0.1 mg
濃度 1 mg/ml
容量 0.1 ml
関連製品
(アイソタイプコントロール)
-
反応性|交差吸着 Human レーザー
抗原 CD314, NKG2D 最大蛍光波長 -
クローン 1D11 最大励起波長 -
ホスト Mouse 標識/Format Azide Free
アイソタイプ IgG1 研究分野 Immunophenotyping
クローナリティ monoclonal 用途

Flow cytometry
Immunoprecipitation
Immunohistochemistry (frozen sections)
Functional assays

Anti-Hu CD314 AZIDFREE,1D11

特異性

The mouse monoclonal antibody 1D11 recognizes CD314 antigen, a 42 kDa C-type lectin-like activating receptor expressed by NK cells, γ/δ T cells, and CD8+ T cells.

抗原情報

CD314 (NKG2D; natural killer receptor G2D or KLRK1; killer cell lectin-like receptor subfamily K, member 1), is a homodimeric C-type lectin-like activating receptor and costimulator with type II membrane orientation (C teminus extracellular). CD314 homodimers are associated with DAP10, a membrane adaptor protein that signals similar to CD28 by recruitment of phosphatidylinositol 3-kinase. Engagement of CD314 amplifies antigen-specific T cell responses in CD314-positive T cell populations. In NK cells, CD314 is a primary activating receptor. As CD314 ligands the MHC class-I chain-related proteins A and B (MICA, MICB) and UL16-binding proteins (ULBPs) have been identified.

利用方法

保存方法

Avoid prolonged exposure to light. Store in the dark at 2-8°C. Do not freeze.

安定性情報

Do not use after expiration date stamped on vial label.

レファレンス

• Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL, Spies T: Activation of NK cells and T cells by NKG2D, a receptor for stress‑inducible MICA. Science. 1999·Jul·30; 285(5428):727‑9. <·PMID:·10426993·>
• Ebert LM, Meuter S, Moser B: Homing and function of human skin gammadelta T cells and NK cells: relevance for tumor surveillance. J·Immunol. 2006·Apr·1; 176(7):4331‑6. <·PMID:·16547270·>
• Hasenkamp J, Borgerding A, Uhrberg M, Falk C, Chapuy B, Wulf G, Jung W, Trümper L, Glass B: Self‑tolerance of human natural killer cells lacking self‑HLA‑specific inhibitoryreceptors. Scand·J·Immunol. 2008·Mar; 67(3):218‑29. <·PMID:·18226015·>
• Sangiolo D, Martinuzzi E, Todorovic M, Vitaggio K, Vallario A, Jordaney N, Carnevale-Schianca F, Capaldi A, Geuna M, Casorzo L, Nash RA, Aglietta M, Cignetti A: Alloreactivity and anti‑tumor activity segregate within two distinct subsets of cytokine‑induced killer (CIK) cells: implications for their infusion across major HLA barriers. Int·Immunol. 2008·Jul; 20(7):841‑8. <·PMID:·18469328·>
• Valencia J, Hernández-López C, Martínez VG, Hidalgo L, Zapata AG, Vicente A, Varas A, Sacedón R: Transient beta‑catenin stabilization modifies lineage output from human thymic CD34+CD1a‑ progenitors. J·Leukoc·Biol. 2010·Mar; 87(3):405‑14. <·PMID:·19952356·>
• Wu J, Cherwinski H, Spies T, Phillips JH, Lanier LL: DAP10 and DAP12 form distinct, but functionally cooperative, receptor complexes in natural killer cells. J·Exp·Med. 2000·Oct·2; 192(7):1059‑68. <·PMID:·11015446·>
• Wu J, Groh V, Spies T: T cell antigen receptor engagement and specificity in the recognition of stress‑inducible MHC class I‑related chains by human epithelial gamma delta T cells. J·Immunol. 2002·Aug·1; 169(3):1236‑40. <·PMID:·12133944·>

Available Safety Data Sheets

CyFlow™ monoclonal antibodies SDS CA EN

Available Technical Data Sheets

CyFlow™ CD314 Azide Free (1D11) BE160427 TDS (US)